Status:
COMPLETED
Pericapsular Nerve Group Block for Total Hip Arthroplasty
Lead Sponsor:
University Tunis El Manar
Conditions:
Hip Arthropathy
Postoperative Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Controlling pain after hip replacement surgery improves comfort and partient satisfaction. Pain after hip replacement has traditionally been managed using systemic pain medications including acetamino...
Detailed Description
The aim of the study was to evaluate the efficacy of the PENG block for intra and postoperative pain control in total hip arthroplasty. it was a monocentric, randomized, controlled and double blind s...
Eligibility Criteria
Inclusion
- primary THA with lateral approach under general anesthesia.
Exclusion
- Hip fracture,
- allergy to local anesthetics,
- peripheral neuropathy,
- creatinin clearance inferior to 30ml/min,
- weight inferior to 50 Kg or superior to 100 Kg,
- neurological disorder affecting the lower extremity, significant psychiatric conditions,
- patients receiving corticosteroid therapy,
- chronic consumption of opioids (\>2 months).
Key Trial Info
Start Date :
April 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04295408
Start Date
April 30 2020
End Date
December 31 2021
Last Update
February 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Kassab D'Orthopedie
Tunis, Tunisia, 2010